Collagen is a vital element for maintaining skin cell turnover and function, and the increased cell activity provided by AHK-Cu may facilitate this process
Presented for research literature review only Lamb DA et al
Must-Have Documentation ICD-10 diagnosis code supporting the procedure Medical necessity with clear symptoms and treatment history Procedure details, including date, provider, and setting Operative Note Essentials Cervical or thoracic region clearly specified Interlaminar approach documented Medication type, dosage, and volume Imaging guidance, if used Best Practices Ensure documentation matches the CPT code billed Link diagnosis codes directly to the procedure Maintain clear and consistent operative notes Strong documentation improves claim approval rates and reduces audit risk
Important Safety Information Do not use AOD-9604 if you: Have a known hypersensitivity to growth hormone fragments or any component of the formulation Have active malignancy (cancer that is currently being treated or monitored) Are pregnant or breastfeeding (insufficient safety data) Have a history of severe allergic reactions to peptide therapies Common side effects (typically mild and transient): Headache, mild gastrointestinal disturbances (flatulence, mild diarrhea at higher doses), upper respiratory tract symptoms, injection site reactions (redness, mild discomfort) Seek medical attention if you experience: Signs of allergic reaction (hives, difficulty breathing, swelling of face or throat), persistent gastrointestinal symptoms, unexplained significant changes in energy, mood, or physical symptoms Clinical Safety Data Safety studies involving approximately 900 participants across six randomized controlled trials documented that AOD-9604 displayed a very good safety and tolerability profile indistinguishable from placebo across most parameters
However, it also plays a potential role in cancer where it supplies tumors with the oxygen and nutrients needed to grow and spread
1 TN is a relatively rare condition, with an estimated annual incidence of 4.3 cases per 100,000 person-years in the US population
